Results 1 - 10 of 868 : 1 2 3 4 5 6 7 8 9 Next
It's Wait Until Next Year for These Drugmakers
Drugs from AstraZeneca and Eli Lilly face delays because of the FDA.
Obama Can't Save Stem Cell Companies
But there are a few companies that can.
What's better than a 52-week low? How about a five-year plunge?
A look back at the telltale signs of one company's meteoric rise.
These stocks have a luster all their own.
Even now, there are still things to be optimistic about.
The market doesn't always cooperate with your plan.
This bullish call comes from more than just one analyst.
Schawk's Packages Deliver Less Revenue
Overall economic slowdown means companies cut advertising and other Schawk products.
5-Star Stocks Poised to Pop: Novartis
Market-trouncing returns could be written in this 5-star.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK